Lineage Cell Therapeutics, Inc.
LCTX
$1.27
$0.0958.12%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 42.29M | 47.91M | 47.81M | 32.71M | 38.50M |
| Total Receivables | 256.00K | 213.00K | 638.00K | 405.00K | 235.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.28M | 1.85M | 2.55M | 1.29M | 1.66M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 17.90K | 17.90K | -- | -- | -- |
| Total Current Assets | 43.84M | 49.98M | 51.00M | 34.40M | 40.39M |
|
|
|||||
| Total Current Assets | 43.84M | 49.98M | 51.00M | 34.40M | 40.39M |
| Net Property, Plant & Equipment | 4.07M | 4.05M | 4.40M | 4.38M | 4.60M |
| Long-term Investments | 10.67M | 10.67M | 10.67M | 10.67M | 10.67M |
| Goodwill | 10.67M | 10.67M | 10.67M | 10.67M | 10.67M |
| Total Other Intangibles | 31.70M | 46.54M | 46.54M | 46.54M | 46.54M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 511.00K | 504.00K | 614.00K | 606.00K | 598.00K |
| Total Assets | 90.80M | 111.75M | 113.22M | 96.59M | 102.80M |
|
|
|||||
| Total Accounts Payable | 1.50M | 2.00M | 1.17M | 1.60M | 2.39M |
| Total Accrued Expenses | 2.95M | 2.98M | 4.26M | 2.88M | 2.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.05M | 1.18M | 1.15M | 1.14M | 1.12M |
| Total Finance Division Other Current Liabilities | 5.26M | 6.93M | 7.39M | 8.25M | 9.14M |
| Total Other Current Liabilities | 5.26M | 6.93M | 7.39M | 8.25M | 9.14M |
| Total Current Liabilities | 10.76M | 13.09M | 13.98M | 13.86M | 15.28M |
|
|
|||||
| Total Current Liabilities | 10.76M | 13.09M | 13.98M | 13.86M | 15.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.11M | 1.06M | 1.36M | 1.61M | 1.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.83M | 19.95M | 20.87M | 16.32M | 18.82M |
| Total Liabilities | 43.69M | 34.10M | 36.21M | 31.80M | 35.93M |
|
|
|||||
| Common Stock & APIC | 490.55M | 489.31M | 484.72M | 469.27M | 467.93M |
| Retained Earnings | -438.07M | -407.60M | -403.47M | -400.19M | -397.16M |
| Treasury Stock & Other | -4.10M | -2.68M | -2.88M | -2.89M | -2.47M |
| Total Common Equity | 48.39M | 79.03M | 78.38M | 66.19M | 68.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.39M | 79.03M | 78.38M | 66.19M | 68.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.27M | -1.37M | -1.37M | -1.39M | -1.43M |
| Total Equity | 47.11M | 77.66M | 77.01M | 64.79M | 66.88M |
|
|
|||||